Search

Refine your search

Content type
Tags
Firm name
Author
Jurisdiction
Language

736 results found

Article

Troutman Pepper | USA | 28 Apr 2021

Cybersecurity Security Best Practices for Retirement Plan Administration

The U.S. Department of Labor’s (DOL) Employee Benefits Security Administration (EBSA) estimates that there are 34 million defined…
Article

Kilpatrick Townsend & Stockton LLP | USA | 31 Mar 2021

Balancing Hatch Waxman and the Sham Litigation Exception

AbbVie Inc. has petitioned the U.S. Supreme Court for a writ of certiorari to review the Third Circuit’s ruling1 determining the biopharma company’s…
Article

Goldberg Segalla LLP | USA | 18 Mar 2021

Valve Manufacturer’s Motion for Summary Judgment Denied

On June 17, 2011, The plaintiffs filed a complaint, alleging that the decedent, Walter Burdick, died as a result of exposure to asbestos or…
Article

Duane Morris LLP | USA | 8 Dec 2020

Patent-Eligible Subject Matter in Biotech Should Recite More Than a "Telescope"

Much of the debate regarding patent-eligible subject matter in biotechnology involves the natural phenomenon or law of nature judicial exceptions.
Article

Shearman & Sterling LLP | USA | 8 Dec 2020

U.S. District Court For The Northern District of Illinois Finds Patent Claims Related To HIV DNA Replication To Be Patent Eligible Under Section 101

On December 1, 2020, the United States District Court for the Northern District of Illinois issued an opinion denying plaintiff Abbott Laboratories’…
Article

Reed Smith LLP | USA | 23 Nov 2020

Reviewing Pre-PREP Act Mass Vaccination Cases

Although as of yet the data has not been peer reviewed, or subjected to the necessary administrative and scientific scrutiny, there has been…
Article

Shawe Rosenthal LLP | USA | 29 Oct 2020

“Me Too” Evidence May Be Admissible for Discrimination Claim

Employers should be warned that other employees’ accounts of their own experiences with discrimination may be admissible to support a Plaintiff’s…
Article

Morrison & Foerster LLP | USA | 26 Oct 2020

Shareholder Proposal No-Action Letters: Morrison & Foerster's 2019-2020 Review

Morrison & Foerster is pleased to share this review of the SEC Staff's 2019-2020 shareholder proposal no-action letters. This review discusses…
Article

Global Competition Review | European Union, USA | 22 Oct 2020

Negotiating the Remedy: A Practitioner’s Perspective

Remedies are a key part of the merger control planning process. While it is up to the parties to propose and implement remedies, their exact form and…
Article

Global Competition Review | India | 22 Oct 2020

Global competition around the world: India

Competition law in India is governed by the Competition Act 2002 (Act) and a number of regulations. Section 5 of the Act states that acquisitions…
Previous page 1 2 3 ...